Kenichiro Shide
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kenichiro Shide.
Osteoporosis International | 2009
Akiko Kuwabara; Kiyoshi Tanaka; Naoko Tsugawa; Hiroshi Nakase; H. Tsuji; Kenichiro Shide; Maya Kamao; T. Chiba; Nobuya Inagaki; Toshio Okano; Shoko Kido
SummaryVitamin K and D deficiency and decreased bone mineral density (BMD) were highly prevalent in patients with inflammatory bowel disease (IBD), especially Crohn’s disease (CD). Dietary intakes of these vitamins, however, were above the Japanese adequate intakes in IBD patients, suggesting that malabsorption is the basis for hypovitaminosis K and D and decreased BMD.IntroductionWe have studied the possible involvement of vitamin K and D deficiency in the pathogenesis of decreased BMD in IBD.MethodsSeventy patients with IBD were evaluated for their BMD; plasma levels of vitamin K; phylloquinone (PK), menaquinone-7 (MK-7), and 25OH-D; serum PTH, protein induced by vitamin K absence (PIVKA-II), and undercarboxylated osteocalcin (ucOC) levels; and their food intake.ResultsCompared with ulcerative colitis (UC) patients, CD patients had significantly lower plasma vitamin K and 25OH-D concentrations; significantly higher serum levels of PTH, PIVKA-II, and ucOC; and significantly lower BMD scores at almost all measurement sites. More IBD patients were vitamin K deficient in bone than in liver. Multiple regression analyses revealed that low plasma concentrations of vitamin K and 25OH-D were independent risk factors for low BMD and that they were associated with the patients’ fat intake, but not with their intake of these vitamins.ConclusionIBD patients have high prevalence of decreased BMD and vitamin K and D deficiency probably caused by malabsorption of these vitamins.
Nutrition | 2013
Erina Joo; Shunsuke Yamane; Akihiro Hamasaki; Norio Harada; Tetsuro Matsunaga; Atsushi Muraoka; Kazuyo Suzuki; Daniela Nasteska; Toru Fukushima; Tatsuya Hayashi; Hidemi Tsuji; Kenichiro Shide; Kinsuke Tsuda; Nobuya Inagaki
OBJECTIVE Ulcerative colitis is a chronic recurrent disease characterized by acute inflammation of the colonic mucosa. In Japan, a dietary supplementation product enriched with glutamine, dietary fiber, and oligosaccharide (GFO) is widely applied for enteral nutrition support. These three components have been suggested to improve intestinal health. In this study, we investigated whether GFO has suppressive effects on mucosal damage in ulcerative colitis in an experimental mouse model. METHODS C57BL/6 mice received 2.5% dextran sulfate sodium in drinking water for 5 d to induce colitis. Then, they were given 0.25 mL of GFO or a 20% glucose solution twice daily for 10 d. Another set of mice receiving unaltered drinking water was used as the normal control group. RESULTS The body weight loss and disease activity index were significantly lower in the GFO-treated mice compared with the glucose-treated mice (P < 0.05). The decrease in colon length induced by dextran sulfate sodium was significantly alleviated in GFO-treated mice compared with glucose-treated mice (P < 0.01). In addition, the histologic findings showed that intestinal inflammation was significantly attenuated in mice treated with GFO. Furthermore, treatment with GFO significantly inhibited the dextran sulfate sodium-induced increase in the mRNA expression of interleukin-1β. CONCLUSION These results suggest that GFO has potential therapeutic value as an adjunct therapy for ulcerative colitis.
The American Journal of Clinical Nutrition | 2011
Kaori Ikeda; Shimpei Fujimoto; Masashi Goto; Chizumi Yamada; Akihiro Hamasaki; Kenichiro Shide; Takashi Kawamura; Nobuya Inagaki
BACKGROUND Factors that affect resting energy expenditure or basal energy expenditure (BEE) in patients with type 2 diabetes under standard treatment have not been evaluated in detail. OBJECTIVE We determined the clinical factors that affected BEE in addition to body composition in patients with type 2 diabetes under standard treatment. DESIGN BEE was measured by using indirect calorimetry under a strict basal condition in 58 Japanese patients with type 2 diabetes after >7 d as inpatients under management of diabetes with medical nutrition therapy and medications. Insulin secretion was measured with a glucagon test. Stepwise regression was applied to explore determinants of BEE. RESULTS In the stepwise estimation, insulin secretion (P = 0.015), insulin therapy (P = 0.012), and pulse rate (P = 0.011) were selected in addition to fat-free mass (FFM) (P < 0.001) and fat mass (P = 0.006) as significant independent determinants of BEE. Standardized partial regression coefficients of the additional 3 factors were -0.16, -0.15, and 0.15, respectively, whereas those for FFM and fat mass were 0.82 and 0.19, respectively. The additional 3 factors explained another 3.9% of the variability of BEE, and the adjusted coefficient of determination was 83.4%. Age, sex, other medications, and parameters of glycemic control were not significant determinants beyond the combined contribution of body composition, endogenous and exogenous insulin, and pulse rate. CONCLUSION Endogenous insulin secretion and exogenous insulin administered in treatment have significant independent effects in the lowering of BEE in patients with diabetes under standard management with medical nutrition therapy and medications.
Journal of Diabetes Investigation | 2011
Chizumi Yamada; Shimpei Fujimoto; Kaori Ikeda; Yuki Nomura; Ami Matsubara; Miwako Kanno; Kenichiro Shide; Kiyoshi Tanaka; Eri Imai; Tsutomu Fukuwatari; Katsumi Shibata; Nobuya Inagaki
Aims/Introduction: To estimate nutritional risk factors for osteoporosis in patients with type 2 diabetes, bone mineral density, homocysteine level, and intakes and levels of Hcy‐related vitamins including folate, vitamin B6 and vitamin B12 were analyzed in a cross‐sectional study.
Progress in Transplantation | 2016
Kanae Asai; Takashi Kobayashi; Hitomi Miyata; Yukari Tanaka; Yoshiyuki Okada; Kaoru Sakai; Hiromitsu Negoro; Tomomi Kamba; Hidemi Tsuji; Kenichiro Shide; Motoko Yanagita; Nobuya Inagaki; Osamu Ogawa
Background: Sodium retention causes posttransplant hypertension, and sodium restriction is recommended in kidney allograft recipients. However, there have been few studies on the impact of dietary counseling on sodium intake and blood pressure (BP) in this population. Objective: To determine the effect of dietary counseling on sodium intake and consequent BP control in kidney allograft recipients. Design, Setting, and Participants: A prospective single-arm study to determine the effect of dietary counseling on sodium intake. Enrolled were renal allograft recipients with sodium intake >100 mEq/d, BP >130/80, antihypertensive use, or body mass index >25 kg/m2. Of 53 renal transplant recipients who met the criteria, 48 participated in the present study. Sodium intake was estimated based on 24-hour urinary sodium excretion before and after 3 sessions of dietary counseling by a board-certified dietitian. Results: Sodium intake was significantly decreased after dietary counseling (158.7 vs 129.6 mEq/d; P = .005). Systolic BP was significantly decreased from 124 mm Hg (interquartile range: 122-134) before counseling to 121 mm Hg (interquartile range: 117-128) after counseling (P < .001). The number of patients with systolic BP >130 mm Hg was decreased by 30% (n = 19-13; P = .07). Among 34 patients on antihypertensive medications, 8 (23.5%) ceased or reduced their drugs due to improvement in BP, whereas 2 increased or changed the drugs due to poor control of BP. Conclusion: Dietary counseling showed a short-term efficacy of reducing sodium intake and clinically relevant BP improvement in renal allograft recipients.
Journal of Diabetes Investigation | 2015
Erina Joo; Atsushi Muraoka; Akihiro Hamasaki; Norio Harada; Shunsuke Yamane; Yaeko Kondo; Kazuyo Suzuki; Daniela Nasteska; Kimitaka Shibue; Takanari Harada; Kanako Iwasaki; Hidemi Tsuji; Kenichiro Shide; Nobuya Inagaki
A dietary supplementation product enriched with glutamine, dietary fiber and oligosaccharide (GFO) is widely applied for enteral nutrition support in Japan. The aim of the present study was to evaluate the effects of GFO ingestion on secretion of incretins, gastric inhibitory polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1), and glucagon‐like peptide‐2 (GLP‐2).
Journal of Clinical Biochemistry and Nutrition | 2015
Eiji Takeda; Hisami Yamanaka-Okumura; Yutaka Taketani; Nobuya Inagaki; Masaya Hosokawa; Kenichiro Shide; Hiroshi Maegawa; Keiko Kondo; Eiji Kawasaki; Shoko Shinozaki; Yuichi Fujinaka; Tsukasa Matsubara; Takafumi Katayama; Hajime Sasaki; Akihiro Kawashima; Hiromitsu Aonuma
The isomaltulose based liquid formula (MHN-01), suppresses postprandial plasma glucose and insulin levels in healthy persons and patients with impaired glucose tolerance (IGT) or type 2 diabetes. MHN-01 intake as a part of breakfast also suppresses glucose and insulin levels after lunch, suggesting second meal effect. The objective of this study was to investigate the effects of nutritional counseling and long-term (24 weeks) MHN-01 ingestion on biomarkers of metabolic syndrome. Forty-one subjects with criteria of metabolic syndrome participated in this study composed with the control period (0–12 week) followed by nutritional counseling and the experimental period (12–36 week) followed by 200 kcal (837 kJ) of MHN-01 or dextrin-based standard balanced liquid formula (SBF) loading as a part of breakfast. In 16 of 41 subjects became to out of criteria for liquid formula loading study during control period (unqualified group). In the unqualified group, several biomarkers were improved. In experimental period, serum HbA1c levels significantly increased in SBF group (n = 12) but did not change in MHN-01 group (n = 10). Thus, intake of 837 kJ MHN-01 as a part of breakfast may be effective for suppression of deteriorating glucose metabolism in metabolic syndrome.
Urology | 2017
Yoshinaga Okumura; Kanae Asai; Takashi Kobayashi; Hitomi Miyata; Yukari Tanaka; Yoshiyuki Okada; Kaoru Sakai; Tomomi Kamba; Hidemi Tsuji; Kenichiro Shide; Kazuaki Nagashima; Motoko Yanagita; Nobuya Inagaki; Osamu Ogawa; Hiromitsu Negoro
OBJECTIVE To investigate whether sodium restriction alters the nocturnal urine volume (NUV) and the ratio of NUV to 24-hour urine of renal allograft recipients (RARs). MATERIALS AND METHODS This prospective, single-center study analyzed 38 of the 59 RARs who were followed up for more than 6 months in our hospital. All patients underwent 3 sessions of dietary counseling performed by a board-certified dietitian. Before and after these 3 sessions, 24-hour urine samples were collected, along with voiding frequency volume charts. RESULTS Of the 38 included RARs, 23 (60.5%) were diagnosed as having nocturnal polyuria (NP, NUV >10 mL/kg). After counseling the RARs with NP, their 24-hour sodium excretion was reduced from 169.5 to 125.6 mEq (P = .0066), their NUV from 862 to 709 mL (P = .021), and the ratio of NUV to 24-hour urine volume from 38.9% to 33.0% (P = .023). In contrast, these parameters were not significantly changed by dietary counseling in RARs without NP. Reduced sodium excretion and decreased NUV were significantly correlated (Spearman rho = 0.45, P = .005). CONCLUSION Excess intake of sodium is considered a cause of NP in RARs. Dietary counseling on sodium restriction is effective in reducing NUV in RARs. Prospective studies are needed to evaluate the general population with NP.
Journal of Diabetes Investigation | 2015
Shiho Ayano-Takahara; Kaori Ikeda; Shimpei Fujimoto; Kanae Asai; Yasuo Oguri; Shin-ichi Harashima; Hidemi Tsuji; Kenichiro Shide; Nobuya Inagaki
Greater glycemic variability and lack of predictability are important issues for patients with type 1 diabetes. Dietary factors are one of the contributors to this variability, but how closely diet is linked to glycemic fluctuation on a daily basis has not been investigated. We examined the association between carbohydrate intake and glycemic excursion in outpatients.
Japanese Clinical Medicine | 2014
Kenichiro Shide; Yuka Takada; Asuka Nakashima; Hidemi Tsuji; Keiko Wada; Akiko Kuwabara; Kiyoshi Tanaka; Nobuya Inagaki
Low protein diet (LPD) plays an important role in preventing the progression of diabetic nephropathy. However, it is a great burden to the patients. In this paper, we have studied the quality of life (QOL) in such patients. The study subjects were 59 patients (male 38, female 21) with type 2 diabetes. The patients were classified into tertiles based on their protein intake (g/kg BW). Scores from the diet-related QOL questionnaire were summarized by principal component analysis into four components; mental health, less burden, satisfaction and merit, and less social restriction. Higher protein intake was associated with less burden and less social restriction. In multiple regression analysis, the significant predictors for the “less burden” component were higher protein intake/BW and estimated glomerular filtration rate (eGFR). In summary, registered dietitians and clinicians must keep in mind that LPD is a serious burden to the patients and efforts must be made to minimize their burden in order to avoid discontinuation.